These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15733463)
41. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794 [TBL] [Abstract][Full Text] [Related]
42. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials. Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333 [TBL] [Abstract][Full Text] [Related]
43. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation]. Gao KF; Liu FY; Chen FJ; Feng YL Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668 [TBL] [Abstract][Full Text] [Related]
45. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis. Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114 [TBL] [Abstract][Full Text] [Related]
46. [Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer]. Wei G; Fang GE; Bi JW; Shen XJ; Nie MM; Xue XC; Hua JD Ai Zheng; 2005 Apr; 24(4):478-82. PubMed ID: 15820074 [TBL] [Abstract][Full Text] [Related]
47. Efficacy of adjuvant interferon-alpha therapy following curative resection in renal cell carcinoma: before the molecular targeting therapy era. Kai F; Takayama T; Sugiyama T; Furuse H; Mugiya S; Ozono S Jpn J Clin Oncol; 2009 May; 39(5):310-4. PubMed ID: 19363055 [TBL] [Abstract][Full Text] [Related]
48. [The role of preoperative embolization in renal cell carcinoma]. Masuda F; Nakada J; Takasaka S; Hishinuma H; Machida T Gan No Rinsho; 1985 Mar; 31(3):289-92. PubMed ID: 3999392 [TBL] [Abstract][Full Text] [Related]
49. [Combined therapy for stage IIIa non-small cell lung cancer]. Zhao LQ; Hou SC; Li H; Hu B; Wang Y Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2030-2. PubMed ID: 16313794 [TBL] [Abstract][Full Text] [Related]
50. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II). Pandha H Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872 [No Abstract] [Full Text] [Related]
51. [The effect of renal artery embolization on the results of treating kidney cancer patients]. Bashe S; Leizering V; Bartusevichene A; Kakhel R; Glazer F Urol Nefrol (Mosk); 1992; (1-3):15-7. PubMed ID: 1384217 [TBL] [Abstract][Full Text] [Related]
52. Is cytotoxic chemotherapy effective in the treatment of advanced renal cell carcinoma? Swanson DA Semin Urol; 1993 Feb; 11(1):35-40. PubMed ID: 7682003 [No Abstract] [Full Text] [Related]
53. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer. Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798 [TBL] [Abstract][Full Text] [Related]
54. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255 [TBL] [Abstract][Full Text] [Related]
55. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate. Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227 [TBL] [Abstract][Full Text] [Related]
56. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764 [TBL] [Abstract][Full Text] [Related]
57. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand. Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558 [TBL] [Abstract][Full Text] [Related]
58. Transcatheter embolization of renal tumors with I-125 particles. Lang EK Digitale Bilddiagn; 1984 Dec; 4(4):165-70. PubMed ID: 6518722 [TBL] [Abstract][Full Text] [Related]
59. No improvement in renal cell carcinoma survival: a population-based study in the Netherlands. Aben KK; Luth TK; Janssen-Heijnen ML; Mulders PF; Kiemeney LA; van Spronsen DJ Eur J Cancer; 2008 Aug; 44(12):1701-9. PubMed ID: 18502115 [TBL] [Abstract][Full Text] [Related]
60. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof]. Zhou JT; Cai ZM; Li NC; Na YQ Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]